New AstraZeneca scheme will pay pharmacists to help patients take their medicines as prescribed
Pharmacists are to be paid by AstraZeneca to talk to patients about taking its medicines as prescribed, the manufacturer told The Journal this week.
Correction (29
March 2008)
Symbicort is one of the four AstraZeneca products involved in the company’s “Making
the most of your medicines” scheme and not Singulair as stated.
The training described is being provided by NPC Plus, not the National Prescribing
Centre itself.
|
Under AZ’s new “Making the most of your medicines” programme,
pharmacists will be able to recruit patients taking Arimidex, Crestor,
Nexium or Singulair with the aim of finding out what medication issue
these patients might have and educating them to improve adherence.
Paul Hudson, primary care director at AZ, said: “We can’t
just send the boxes to the pharmacy and think our responsibility has
ended. I think as the pharmacist’s role grows, and as the professional
component — the fee-for-service component — grows, we want
to be part of that.
“We want a healthy relationship with pharmacy for
the right reasons. Our programme happens very much after the prescribing
decision has been made. This is not about influencing the prescriber
it is about influencing patients to comply with treatment for a better
outcome.”
After gaining patient consent, the pharmacist will be expected to get
the patient to fill in a questionnaire about their medicine-taking behaviour.
The results of this will then be used by the pharmacist to facilitate
a discussion about adherence.
Pharmacists are to be paid £10 for each of up to three consultations
per patient, and £5 for each of three follow-up submissions of
data to AZ — a potential earning of £45 for each patient.
The company expects each pharmacist might recruit around 60 patients
in the first year of the programme.
Pharmacists wishing to take part will be provided with training from
the National Prescribing Centre to strengthen their consultation skills.
A range of resources have also been adapted to facilitate the discussions.
Further information is available online |